Russell Investments Group, Ltd.

Position in FULC — Fulcrum Therapeutics, Inc.

CIK 1692234 Seattle, WA

Position in FULC

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$607,130

+$566,709 QoQ

Shares Held

79,157

+2114.8% QoQ

Ownership

0.119%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

11 quarters on record

Voting authority Sole 85.67025026213727.ToString("F0")% Shared 0.ToString("F0")% None 14.329749737862729.ToString("F0")%

Healthcare · as of Mar 31, 2026

Russell Investments Group, Ltd. holds $1,223,802,944 across 266 Biotechnology names. FULC ranks #120 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	228,086	$176,228,356
2	VRTX	Vertex Pharmaceuticals Inc / Ma	367,691	$164,188,731
3	RPRX	Royalty Pharma plc	1,397,958	$67,060,041
4	INCY	Incyte Corp	638,242	$60,071,331
5	ALNY	Alnylam Pharmaceuticals, Inc.	147,533	$48,814,236
6	MRNA	Moderna, Inc.	710,640	$36,100,509
7	BMRN	Biomarin Pharmaceutical Inc	606,224	$34,245,589
8	INSM	INSMED Inc	169,162	$27,661,365

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$607,130	79,157	+2114.8%	Shares	Defined	2026-05-08
2025-12-31	$40,421	3,574	-74.0%	Shares	Defined	2026-02-17
2025-09-30	$126,324	13,731	+47.5%	Shares	Defined	2025-11-13
2025-06-30	$64,038	9,308	+4209.3%	Shares	Defined	2025-08-13
2025-03-31	$622	216	-31.2%	Shares	Defined	2025-05-13
2024-12-31	$1,475	314	+568.1%	Shares	Defined	2025-02-13
2024-09-30	$167	47	-94.9%	Shares	Defined	2024-11-13
2023-03-31	$2,636	925	-28.8%	Shares	Defined	2023-05-09
2020-12-31	$15,223	1,300	0.0%	Shares	Defined	2021-02-08
2020-09-30	$10,309	1,300	0.0%	Shares	Defined	2020-11-09
2020-06-30	$23,777	1,300	—	Shares	Defined	2020-08-05
No filing history on record for this holder in this stock.